SCHEMBL27576407

SCHEMBL27576407

Cc1ccc(N=S(=O)=O)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PMM2 O15305 1/20 0.41
▸ MPI P34949 1/20 0.41
▸ ALDH1A1 P00352 8/20 0.37
▸ TRPA1 O75762 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAPT P10636 6/20 0.35
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ POLB P06746 3/20 0.33
▸ PSMD14 O00487 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MCL1 Q07820 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27716615 0.81 TDP1 (0.45) ALDH1A1TRPA1CYP3A4MAPTSMN1; SMN2
SCHEMBL28294225 0.79 KIF11 (0.32) TRPA1CYP3A4
SCHEMBL28161117 0.75 BRD4 (0.42) LMNAPOLB
SCHEMBL8990517 0.73 TDP1 (0.42) ALDH1A1CYP3A4MAPTSMN1; SMN2RAB9A
SCHEMBL8935677 0.73 ALDH1A1 (0.44) PMM2MPIALDH1A1TRPA1CYP3A4
SCHEMBL28672997 0.73 ALDH1A1 (0.44) ALDH1A1CYP3A4TDP1TSHRPOLB
SCHEMBL11516839 0.72 KMT2A (0.45) PMM2MPIALDH1A1TRPA1CYP3A4
SCHEMBL11516843 0.72 KMT2A (0.45) PMM2MPIALDH1A1TRPA1CYP3A4
SCHEMBL31264508 0.72 KMT2A (0.45) PMM2MPIALDH1A1TRPA1CYP3A4
Ammonia Solution, Strong SCHEMBL28131657 0.71 TDP1 (0.40) ALDH1A1CYP3A4MAPTSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1356977-A Glucagon antagonists/inverse agonists NOVO NORDISK AS (DK) 2002-07-03 — — CN disclosed
Send feedback